We have established that an algorithmically reconstructed molecular pathway centered around FREM2 predicts negative associations with survival and molecular and histological subtypes of gliomas considerably more strongly than the paternal gene FREM2 alone (Zolotovskaia et al., 2021). Here, FREM2 is linked to central nervous system cancer.